Wyoming Telehealth Prescribing: Establishing a Valid Provider-Patient Relationship and Regulatory Compliance

Wyoming has established clear guidelines governing the practice of telemedicine, particularly concerning the establishment of a provider-patient relationship and the prescribing of medications. These regulations are crucial for any healthcare business, including telehealth platforms, medspas, dental practices, and chiropractic offices, seeking to provide services to patients within the state.

Establishing the Provider-Patient Relationship via Telehealth

Central to Wyoming's telehealth framework is the requirement for a properly established provider-patient relationship before a practitioner can prescribe medication via telemedicine. The Wyoming Board of Medicine's rules, specifically Chapter 7, Section 2, outline these requirements. For a provider-patient relationship to be established through telehealth for the purpose of prescribing, it generally requires a real-time, interactive audio-visual encounter.

This means that a simple questionnaire, email exchange, or even an audio-only consultation, while potentially useful for certain aspects of care, typically does not suffice for the initial establishment of a relationship that permits prescribing. The intent is to ensure that the practitioner has sufficient information and direct interaction to make an informed clinical judgment, comparable to an in-person visit.

Key Requirements for Relationship Establishment:

• Interactive Audio-Visual Communication: The primary method for establishing the relationship must involve a live, two-way audio and visual connection between the patient and the practitioner. This allows for visual assessment and direct communication.
• Patient Consent: Informed consent for telehealth services must be obtained from the patient, detailing the nature of the services, potential risks, and benefits.
• Medical Record Documentation: Comprehensive documentation of the telehealth encounter, including the method of communication, findings, diagnoses, and treatment plan, must be maintained in the patient's medical record.
• Standard of Care: The practitioner is expected to adhere to the same standard of care as if the services were provided in person. This includes conducting an appropriate patient history, physical examination (to the extent possible via telehealth), and medical decision-making.

(Source: Wyoming Board of Medicine, Rules and Regulations, Chapter 7, Section 2. Available at: https://wyomedboard.wyo.gov/rules-and-regulations)

Telehealth Prescribing of Non-Controlled Substances

Once a valid provider-patient relationship has been established in accordance with the above criteria, a practitioner may prescribe non-controlled substances via telehealth. This prescribing must be based on a legitimate medical purpose, within the scope of the practitioner's license, and after a thorough assessment of the patient's condition. The practitioner must also ensure that the prescription is appropriate and safe for the patient, considering their medical history and current medications.

Telehealth Prescribing of Controlled Substances

Wyoming maintains a more restrictive stance on the prescribing of controlled substances via telehealth. Generally, the initial prescription of a controlled substance requires an in-person examination by the prescribing practitioner. This aligns with the federal Ryan Haight Online Pharmacy Consumer Protection Act of 2008, which generally requires an in-person medical evaluation before a controlled substance can be prescribed via the internet.

Exceptions to the In-Person Rule for Controlled Substances:

While the general rule is strict, there are limited exceptions:

1. Follow-up Care: After an initial in-person examination, subsequent prescriptions for controlled substances may be issued via telehealth if the practitioner has established a legitimate medical purpose and is conducting ongoing management of the patient's condition.
2. Consultation with Another Practitioner: If a practitioner is prescribing a controlled substance based on the recommendation of another practitioner who has conducted an in-person examination, this may be permissible.
3. Public Health Emergencies: During a declared public health emergency, federal and state waivers may temporarily relax these restrictions. For example, during the COVID-19 Public Health Emergency, federal waivers allowed for the prescribing of controlled substances via telehealth without an initial in-person exam under certain conditions. However, these waivers are temporary and revert to the original rules once the emergency declaration expires.

(Source: Wyoming Board of Medicine, Rules and Regulations, Chapter 7, Section 2. Available at: https://wyomedboard.wyo.gov/rules-and-regulations) (Source: U.S. Drug Enforcement Administration (DEA) guidance on Ryan Haight Act. Available at: https://www.dea.gov/)

Implications for Healthcare Businesses

Telehealth Brands and Platforms

Telehealth companies must design their patient intake and consultation workflows to comply with Wyoming's requirement for interactive audio-visual encounters for initial prescribing. Platforms relying solely on asynchronous communication or audio-only calls for initial assessments that lead to prescriptions will likely fall short of the state's requirements. For controlled substances, a clear protocol for in-person evaluations or adherence to specific, limited exceptions is essential.

Medspas and Aesthetic Practices

Medspas that utilize telehealth for initial consultations for treatments involving prescription medications (e.g., certain neurotoxins, dermal fillers, or topical prescriptions) must ensure these consultations are conducted via live video. Any prescribing of controlled substances, even for pain management post-procedure, would typically necessitate an in-person visit unless a valid exception applies. This impacts the feasibility of fully remote prescribing models for aesthetic services.

Dental Practices

Dentists in Wyoming using telehealth for initial patient evaluations that may lead to prescriptions (e.g., antibiotics for infection, pain medication) must ensure the initial encounter is a real-time audio-visual interaction. Prescribing controlled substances for acute pain management post-procedure via telehealth would generally require an initial in-person examination.

Chiropractic Offices

While chiropractors typically do not prescribe medications, those who may collaborate with other practitioners or integrate services that involve prescribing must be aware of these regulations. If a chiropractic practice were to expand into services requiring prescriptions, they would need to ensure compliance with the provider-patient relationship and prescribing rules.

Best Practices for Compliance

To ensure compliance with Wyoming's telehealth prescribing laws, healthcare businesses should implement the following best practices:

• Robust Technology: Utilize telehealth platforms that reliably support secure, real-time, interactive audio-visual communication.
• Informed Consent: Develop and implement a comprehensive informed consent process specifically for telehealth services, clearly outlining the nature of the services, privacy practices, and limitations.
• Clear Protocols: Establish clear internal protocols for practitioners regarding when and how a provider-patient relationship can be established via telehealth for prescribing purposes.
• Controlled Substance Policy: Implement a strict policy for controlled substance prescribing via telehealth, adhering to the in-person examination requirement and documenting any applicable exceptions.
• Documentation: Maintain meticulous medical records for all telehealth encounters, including details of the communication modality, assessment findings, diagnoses, and treatment plans.
• Practitioner Training: Ensure all practitioners are thoroughly trained on Wyoming's specific telehealth laws and regulations, including the nuances of establishing a provider-patient relationship and prescribing.
• Regular Review: Periodically review and update telehealth policies and procedures to reflect any changes in state or federal regulations.

Conclusion

Wyoming's regulatory framework for telehealth prescribing emphasizes patient safety and the maintenance of a robust standard of care. The requirement for an interactive audio-visual encounter to establish a provider-patient relationship for prescribing, coupled with strict rules for controlled substances, necessitates careful adherence by all healthcare businesses. Proactive compliance and robust internal policies are essential to navigate this landscape successfully and avoid potential regulatory scrutiny from the Wyoming Board of Medicine or other relevant licensing bodies.